When does Boston Scientific report earnings?

Boston Scientific Corporation · end-of-day data as of Nov 13, 2026

Boston Scientific

BSX · $64.27B

$44.34+0.3%

Nov 13, 2026 · close

▲ 9

PT$54.04 +21.9%
ConsensusBuy · 32
P/E vs own-32.6%
P/E vs sector-41.7%
FCF yield+5.2%
Insiders$100K
MA20×50Golden 3d ago
MACD0.07
Sector▲ +15.9%

Neutral

Earnings in82d
P/E18.8x
RSI50
Support-4.2%
Resistance+2.6%
Off 52w high-57.6%
Volume0.5x
Bollingerlower half
52w range$40–$105
ATR+3.8%
Off ATH-59.5%

▼ 3

News
Trendbearish
MAs1 of 4

Updates with the 15-min delayed price. Not a forecast or investment advice.

Boston Scientific BSX reports its next earnings on Wednesday, Feb 3, 2027, before the open, an estimated date the company has not confirmed yet. Analysts expect EPS of $0.78 on revenue of $5.18B. Boston Scientific beat the EPS estimate in 6 of its last 8 reports, and the stock moved ±5.8% on average the session after. The last report, on Oct 28, 2026: EPS of $0.73 against $0.73 expected and revenue of $5.14B against $5.09B; the stock fell 5.8% the next session.

The stock around its reports

Last close $44.34 · -49.9% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue +1.4% year over year, free cash flow 16.9% of revenue, operating margin 19.1%.

RevenueFree cash flow


Q3 FY2026	Sep 30, 2026	$5.14B	0.40	$868M	66.7%	19.1%	11.2%
Q2 FY2026	Jun 30, 2026	$5.44B	0.61	$1.28B	70.7%	21.6%	16.7%
Q1 FY2026	Mar 31, 2026	$5.2B	0.90	$171M	69.4%	20.6%	25.7%
Q4 FY2025	Dec 31, 2025	$5.29B	0.45	$1.01B	74.5%	22.8%	12.6%
Q3 FY2025	Sep 30, 2025	$5.07B	0.50	$1.16B	69.9%	20.7%	14.9%
Q2 FY2025	Jun 30, 2025	$5.06B	0.53	$1.1B	67.7%	16.2%	15.7%
Q1 FY2025	Mar 31, 2025	$4.66B	0.45	$354M	63.3%	19.2%	14.5%
Q4 FY2024	Dec 31, 2024	$4.56B	0.38	$1.16B	58.6%	12.9%	12.4%